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Nearly 8000 children are diagnosed with cancer each year in the
USA (Bleyer, 1990), and for the vast majority, the aetiology is
unknown. Based primarily on the temporal and age-specific
patterns for specific childhood malignancies (including acute
lymphoblastic leukaemia (ALL), non-Hodgkin’s lymphoma
(NHL) and Hodgkin’s disease (HD)), hypotheses relating to infec-
tious agents have been proposed (Mueller, 1991; Kinlen, 1995;
Greaves, 1997; Smith et al, 1998; Westerbeek et al, 1998). For
example, childhood ALL demonstrates a peak in incidence
between 2 and 5 years of age. This age peak was first observed in
the 1930s for US white children and was subsequently noted in the
1960s for US black children. The peak is absent in African coun-
tries. Several theories suggest that this age peak may be due to
exposure(s) to an infectious agent(s) (reviewed in Ross et al,
1994). Clusters of childhood leukaemia in space and time have
also been reported in several countries, and offer some support
for an infectious aetiology (Ross et al, 1994). Despite these
observations, however, no infectious agent has been definitively
linked with childhood ALL. Based largely on these ecological
observations suggesting an infectious aetiology, numerous investi-
gators have explored whether seasonal variations exist in the diag-
nosis month (or birth month) of children with leukaemia (or other
related malignancies), with inconsistent results (Hayes, 1961; Lee,
1962, 1963; Fraumeni, 1963; Bjelke, 1964; Knox, 1964;
Lanzkowsky, 1964; Mainwaring, 1966; Stark and Mantel, 1967;
Till, 1967; Gunz and Spears, 1968; Fekety and Carey, 1969;
Walker and Van Noord, 1982; van Steensel-Moll et al, 1983;
Harris and Al-Rashid, 1984; Harris et al, 1987; Meltzer et al, 1996;
Badrinath et al, 1997; Gilman et al, 1998; Westerbeek et al, 1998).
A demographic database was established in the USA to investi-
gate the geographic distribution of over 20 000 children with
cancer diagnosed between 1989 and 1991 in the Children’s Cancer
Group (CCG) and the Pediatric Oncology Group (POG) (Ross
et al, 1993, 1996). This large database provided a unique oppor-
tunity to examine whether seasonal variations exist in the diag-
nosis of childhood ALL, HD, or NHL. Moreover, the large number
of cases enabled us to explore potential seasonal variations in the
diagnosis of other childhood malignancies.
MATERIALS AND METHODS
Data from this study were derived from information on patients
seen at one of the member institutions of the CCG or the POG and
have been previously described (Ross et al, 1993, 1996; Swensen
et al, 1997). Briefly, data were collected on 21 026 incident
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Summary Seasonal trends in month of diagnosis have been reported for childhood acute lymphoblastic leukaemia (ALL) and non-Hodgkin’s
lymphoma (NHL). This seasonal variation has been suggested to represent an underlying viral aetiology for these malignancies. Some
studies have shown the highest frequency of diagnoses in the summer months, although this has been inconsistent. Data from the Children’s
Cancer Group and the Pediatric Oncology Group were analysed for seasonal incidence patterns. A total of 20 949 incident cancer cases
diagnosed in the USA from 1 January 1989 through 31 December 1991 were available for analyses. Diagnosis-specific malignancies
available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin’s disease, NHL, rhabdomyosarcoma, neuroblastoma,
retinoblastoma, osteosarcoma, Wilms’ tumour, retinoblastoma, Ewings’ sarcoma, central nervous system (CNS) tumours and
hepatoblastoma. Overall, there was no statistically significant seasonal variation in the month of diagnosis for all childhood cancers combined.
For diagnosis-specific malignancies, there was a statistically significant seasonal variation for ALL (P = 0.01; peak in summer),
rhabdomyosarcoma (P = 0.03; spring/summer) and hepatoblastoma (P = 0.01; summer); there was no seasonal variation in the diagnosis of
NHL. When cases were restricted to latitudes greater than 40° (‘north’), seasonal patterns were apparent only for ALL and hepatoblastoma.
Notably, 33% of hepatoblastoma cases were diagnosed in the summer months. In contrast, for latitudes less than 40° (‘south’), only CNS
tumours demonstrated a seasonal pattern (P = 0.002; winter). Although these data provide modest support for a summer peak in the
diagnosis of childhood ALL, any underlying biological mechanisms that account for these seasonal patterns are likely complex and in need of
more definitive studies. © 1999 Cancer Research Campaign
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Table 1 Distribution of childhood cancer cases by month of diagnosis
Diagnosis Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Roger’s
test
Overall 1806 1674 1747 1724 1824 1722 1778 1916 1638 1765 1763 1592 P = 0.12
n = 20 949 (8.6)a (8.0) (8.3) (8.2) (8.7) (8.2) (8.5) (9.2) (7.8) (8.4) (8.4) (7.6)
ALL 452 398 447 478 492 467 496 495 460 456 467 424 P = 0.01
n = 5532 (8.2) (7.2) (8.1) (8.6) (8.9) (8.4) (9.0) (9.0) (8.3) (8.2) (8.4) (7.7)
AML 91 94 97 97 86 105 106 113 92 94 87 91 P = 0.33
n = 1153 (7.9) (8.2) (8.4) (8.4) (7.5) (9.1) (9.2) (9.8) (8.0) (8.2) (7.6) (7.9)
HD 102 84 88 98 98 97 83 101 96 88 111 96 P = 0.62
n = 1135 (9.0) (7.4) (7.8) (8.6) (8.6) (8.5) (7.3) (8.9) (8.5) (7.8) (9.8) (8.5)
NHL 107 102 107 107 131 97 131 105 103 116 113 106 P = 0.71
n = 1325 (8.1) (7.7) (8.1) (8.1) (9.9) (7.3) (9.9) (7.9) (7.8) (8.8) (8.5) (8.0)
NB 141 114 130 129 142 103 129 120 121 114 135 117 P = 0.42
n = 1495 (9.4) (7.6) (8.7) (8.6) (9.5) (6.9) (8.6) (8.0) (8.1) (7.6) (9.0) (7.8)
Rb 39 33 32 37 30 34 24 41 29 39 35 29 P = 0.77
n = 402 (9.7) (8.2) (8.0) (9.2) (7.5) (8.5) (6.0) (10.2) (7.2) (9.7) (8.7) (7.2)
WT 90 105 100 107 121 107 113 112 89 119 92 90 P = 0.08
n = 1245 (7.2) (8.4) (8.0) (8.6) (9.7) (8.6) (9.1) (9.0) (7.1) (9.6) (7.4) (7.2)
RD 62 81 89 68 86 68 65 99 51 53 70 69 P = 0.03
n = 861 (7.2) (9.4) (10.3) (7.9) (10.0) (7.9) (7.5) (11.5) (5.9) (6.2) (8.1) (8.0)
OS 63 70 56 61 67 57 60 84 61 86 61 50 P = 0.31
n = 776 (8.1) (9.0) (7.2) (7.9) (8.6) (7.3) (7.7) (10.8) (7.9) (11.1) (7.9) (6.4)
ES 48 29 37 40 31 39 39 47 32 35 32 28 P = 0.69
n = 437 (11.0) (6.6) (8.5) (9.2) (7.1) (8.9) (8.9) (10.8) (7.3) (8.0) (7.3) (6.4)
CNS 365 335 325 306 313 309 306 339 286 341 323 307 P = 0.09
n = 3855 (9.5) (8.7) (8.4) (7.9) (8.1) (8.0) (7.9) (8.8) (7.4) (8.9) (8.4) (8.0)
HB 17 12 21 15 20 32 20 23 22 17 17 12 P = 0.01
n = 228 (7.5) (5.3) (9.2) (6.6) (8.8) (14.0) (8.8) (10.1) (9.7) (7.5) (7.5) (5.3)
aPercentage of total by diagnosis category. ALL=acute lymphoblastic leukaemia; AML=acute myeloid leukaemia; HD=Hodgkin’s disease; NHL=non-Hodgkin’s
lymphoma; NB=neuroblastoma; Rb=retinoblastoma; WT=Wilms’ tumour; RD=rhabdomyosarcoma; OS=osteosarcoma; ES=Ewing’s sarcoma; CNS =central
nervous system; HB=hepatoblastoma.
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Table 2 Studies that have explored childhood cancer and seasonality
Author, year Data analysed No. of cases, age group, Findings Statistical test/comment
published, place malignancy
Hayes, 1961, USA Patients seen at a 184 patients with acute Excess of cases with clinical onset All months (c2)
North Carolina leukaemia ages 0–78 and/or diagnosis in the winter
hospital; 1943–1958 years months
Lee, 1962, 1963, National Cancer 2130 patients with Summer (May–October) All months (c2)
England and Wales Registration acute leukaemia ages preponderance of ALL for both
Scheme 0–19 years; 2570 age groups; slight summer excess
patients with acute of AML in older age group
leukaemia ages 20–44
years
Fraumeni, 1963, USA National 511 cases < 16 years Winter/spring excess of leukaemia; All months (c2)
Cooperative of age particularly ALL
Leukemia Study;
1958–1961
Bjelke, 1964, Norway Cancer Registry of 242 children < 20 No seasonal patterns in month of All months (c2)
Norway, 1953–1958 years of age with diagnosis
leukaemia
Knox, 1964, England Northern England; < 185 children May–October preponderance of Summer–winter ratios (c2)
1951–1960 diagnosed < 15 years clinical onset in children less than
of age; acute leukaemia 6 years of age
Lanzkowsky, 1964, Paediatric Teaching 40 children < 14 years Winter excess (June–August) of Visual plots
South Africa Unit of the of age childhood acute leukaemia
University of
Capetown; 1959–1964
Mainwaring, 1966, Diagnosis records 74 children < 15 years No seasonal patterns in the date All months (c2)
London from a hospital in of age with leukaemia of onset of leukaemia
Liverpool, 1955–1964
Stark and Mantel, Michigan death 706 children < 15 No seasonal pattern in the month All months (c2)
1967, USA records; 1950–1964 years of age who died of birth of cases
of leukaemia
Till et al, 1967, UK London death 618 children < 15 No seasonal patterns in date of All months (c2)
certificates, 1952–1961 years of age with onset
leukaemia
Gunz and Spears, Cancer Death Lists A total of 1003 Peak in summer for adults, not for All months (c2 and
1968, New Zealand in New Zealand; children and adults children goodness of fit test)
1953–1964 with leukaemia
Fekety and Carey, Johns Hopkins < 20 years of age; Late spring/early summer excess Visual plots
1969 Hospital 96 children with acute in leukaemia onset
leukaemia
Walker and Van SEER program and 7000 cases of No seasonal patterns for either all Edward’s test; did not explore
Noord, 1982, USA TNCS*; 1969–1981 leukaemia; all ages; leukaemia or for different cell types patterns with respect to
also by leukaemia type or age groups geography
van Steensel-Moll et Dutch Childhood 293 children < 15 with No seasonal variations by age, sex Edwards, Knox and Mantel
al, 1983, Netherlands Leukemia Study leukaemia or leukaemia type methods
Group; 1973–1980
Harris and Al-Rashid, 18 hospitals and 101 children < 15 Spring (March, April) and late Analysis of variance
1984 medical centres in years of age with ALL summer–early fall excess (August,
Nebraska, 1971–1980 September) of ALL
Harris et al, 1987 SEER data + 1221 children < 20 Statistically significant peaks Periodic regression analysis
Nebraska; 1973–1980 with ALL occurred in April, August and evaluating four types of sinusoidal
December for cases who resided curves: unimodal, bimodal,
in US locations above 40°; trimodal or quatrimodal; also
and in February, July and evaluated above and below 40°
October for cases who resided in latitude
locations below 40°
Meltzer et al, 1996, SEER data, 1973–1986 1487 children < 15 No statistically significant Cosinor analysis; also evaluated
USA with ALL association with month of birth geographical regions
and childhood ALL was found
Badrinath et al, 1997, East Anglian 338 children < 15; Significant 40% summer excess in Summer–winter ratios
UK Cancer Registry, 3954 adults; all month of diagnosis for ALL both in
1971–1994 leukaemias children and adults
Gilman et al, 1998, UK Oxford Survey of 9207 children with Little evidence of seasonality for Summer–winter ratios(c 2)
Childhood Cancers; leukaemia under 15; the overall group; suggestion of
1953–1981 including 5312 ALL seasonality (summer peak) in a
regional data set (West Midlands)
Westerbeek et al, Manchester 1070 children < 15 Statistically significant winter peak Edward’s test
1998, UK Children’s Tumour with ALL; in date of first symptom for
Registry, 1954–1996 244 children < 15 with common ALL and HD; using date
AML; 166 children of diagnosis and summer/winter
< 15 with HD; 189 ratios for ALL, a significant
children with NHL summer excess was noted as in
the Badrinath study above
*TNCS= Third National Cancer Survey.childhood cancer cases (less than 20 years of age) diagnosed in
the continental USA (i.e. excluding Hawaii and Alaska) by a
member institution of CCG or POG between 1 January 1989 and
31 December 1991. Data collected included date of birth, date of
diagnosis, sex, race, diagnosis code and the zip code of residence
at the time of diagnosis. Zip codes were used to determine latitude
position. For this analysis, a subset of cases (n = 77) had missing
or insufficient data (e.g. lacking month) on date of diagnosis or
date of birth. Thus, a total of 20 949 cases were evaluated for
seasonal variations in the date of diagnosis.
Childhood cancers explored in this study included ALL, acute
myeloid leukaemia (AML), HD, NHL, retinoblastoma (Rb),
central nervous system (CNS) tumours, rhabdomyosarcoma (RD),
hepatoblastoma (HB), Wilms’ tumour (WT), osteosarcoma (OS),
Ewing’s sarcoma (ES) and neuroblastoma (NB).
Statistical analysis
Seasonal trends (adjusted for the number of days in a month) were
evaluated with Roger’s test and maximum likelihood estimates
(Roger, 1977). Roger’s test is a modification of Edward’s test and
evaluates the significance for cyclic trends based on the efficient
score vector calculated for one seasonal peak (Edwards, 1961;
Roger, 1977; Epilog, EpiCenter Software). Additional peaks were
evaluated by a maximum likelihood model that fits an order 1
model, then order 2, etc. Plots of the number of cases of childhood
cancer by month of diagnosis were also examined. Three-month
moving means were used in the plots to assist in visual evaluation
of seasonal trends.
RESULTS
Table 1 shows the overall distribution of cases by month of diag-
nosis, and by diagnosis-specific subgroups. Although there were
some months (January, May and August) where there was a
notably higher frequency of cases overall, the test for seasonal
trend was not significant (P = 0.12). For the individual diagnostic
groups, there was a statistically significant summer peak evident
for ALL (P = 0.01), RD (P = 0.03) and HB (P = 0.01) (Table 1 and
Figure 1). Marginally significant peaks were observed for WT
(summer) and CNS tumours (winter) (P = 0.08 and 0.09 respec-
tively). No statistically significant seasonal patterns were detected
for AML (although there were notably more cases in the summer),
osteosarcoma (notable fall peak), HD, NHL, NB, RB, or all other
tumours combined.
When the cases were stratified by northern and southern lati-
tudes, several different patterns were apparent (data not shown).
For cases living in the southern USA, with the exception of a
winter peak for CNS tumours (P = 0.002), there were no statisti-
cally significant seasonal patterns. For cases living in the northern
USA, there was a statistically significant summer peak for both
ALL (P = 0.004) and HB (P = 0.03).
DISCUSSION
In an evaluation of over 20 000 children diagnosed with cancer in
the USA, we found statistically significant seasonal variations in
the diagnosis of several malignancies including ALL (summer
peak), HB (summer peak) and RD (spring/summer peak).
A summer excess in the diagnosis of childhood ALL has been
reported in several studies (Lee, 1962, 1963; Knox, 1964; Fekety,
1969; Badrinath et al, 1997; Westerbeek et al, 1998) (Table 2).
Others have found no seasonal variations in childhood ALL
(Bjelke, 1964; Mainwaring, 1966; Till, 1967; Gunz, 1968; Walker,
1982; van Steensel-Moll et al, 1983; Gillman et al, 1998), a winter
excess (Hayes, 1961; Fraumeni, 1963; Lanzkowsky, 1964), or a
more complex (multiseasonal) pattern (Harris and Al-Rashid,
1984; Harris et al, 1987). Harris et al (1987) compared seasonal
risk of childhood ALL in cases diagnosed in the northern USA
(greater than 40° latitude) including Seattle, Nebraska, Iowa,
Detroit and Connecticut with cases diagnosed in the southern USA
(less than 40° latitude) including San Francisco, Utah, New
Mexico and Atlanta. They found more complex trimodal patterns,
with seasonal peaks in April, August and December for northern
cases, and seasonal peaks in February, July and October for the
southern locations. They suggest that these peaks could coincide
with seasonal elevations in the occurrence of allergic and infec-
tious processes, including a higher frequency of tree and grass
pollen in the spring, ragweed in the summer and influenza in the
winter. In our study, when cases were stratified on latitude, a
summer excess for ALL was only apparent for children who
resided in the northern USA; there was no suggestion of a trimodal
seasonal pattern. Others who have observed only singular summer
peaks in ALL diagnosis also speculate that a cyclic pattern in an
infectious exposure may account for the patterns observed (Gunz
and Spears, 1968; Badrinath et al, 1997). While it is acknowledged
that exact patterns of seasonality in potential infectious agents
cannot be easily delineated, attention to the occurrence of infec-
tions in children with leukaemia prior to diagnosis in epidemiolog-
ical studies may be fruitful.
The excess of childhood AML diagnosed in the summer,
although not statistically significant, may still be important to
note. While ALL and AML are biologically different diseases and
may have distinct aetiologies (Ross et al, 1994), there is no reason
to think that an infectious component must only be limited to ALL.
It is possible that different infectious agents may play a separate
role in the development of each of these diseases. This preliminary
evidence for a summer peak in AML merits further investigation.
The fall peak in osteosarcoma is visually striking but not statis-
tically significant. We also found summer peaks in the diagnosis of
RD, HB and WT. We observed no seasonal patterns among chil-
dren diagnosed with CNS tumours in the northern states. There did
appear to be a winter peak, however, among children in the
southern states.
In light of the fact that these observations have not been
reported in other populations and that we did not have an a priori
hypothesis regarding diagnostic seasonality at these sites, caution
should be used in drawing any conclusions based solely on these
data.
Several potential limitations of this study need to be considered.
First, this was an ecological analysis. We had no information at the
individual level on potential confounding factors. Second, a
number of different childhood tumours were evaluated for
seasonal patterns in this study. While there were a priori
hypotheses for some of these (such as ALL and NHL), most of the
sites were evaluated on a hypothesis-generating basis. In fact, the
finding of a summer peak for multiple sites within this analysis
provides some evidence against a causal interpretation of the
results for ALL. Third, we did not have information on the month
of onset of clinical symptoms. This date may be the more impor-
tant indicator, especially for ALL, since there may be considerable
variability in the time period from first appearance of symptoms to
552 JA Ross et al
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over a period of 3 years. It is possible that if the patterns of
seasonal diagnosis of a specific cancer are dependent on exposure
to infectious agents, then these seasonal patterns might vary from
year to year in the same way that infections do. On the other hand,
the cyclical patterns involved in exposure to infectious agents
might occur over a longer time frame (i.e. greater than 3 years).
Fifth, this type of study is unable to evaluate exposure to specific
infectious agents. Finally, because the aetiology of most cancers is
likely multifactorial, not all cases would necessarily have an infec-
tious cause. This mixing of effects, however, would probably
result in an underestimate of any putative seasonal influence.
In summary, this study provides some modest support for a
summer excess in the diagnosis of childhood ALL. Given all the
available evidence, it seems reasonable to suggest that these data
may reflect some underlying pattern of exposure to infectious
agents. While no specific agent has yet been identified and associ-
ated with the development of childhood ALL, the theories of
Greaves (1997), Kinlen (1995) and Smith (Smith et al, 1998)
deserve serious attention and investigation. If there are underlying
biological mechanisms that account for the seasonal patterns
observed here and in other preliminary studies, they are very likely
to be complex and difficult to unravel. We suggest that further
studies are most likely to be fruitful only if they are based on a
more detailed investigation of specific hypotheses relating to
specific infectious agents.
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